CAPTRUST Financial Advisors
PFE icon

CAPTRUST Financial Advisors’s Pfizer PFE Stock Holding History

CAPTRUST Financial Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,200
Closed -$40 – 2761
2023
Q3 		$40 Buy
+1,200
New +$42.4K ﹤0.01% 2608

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

CAPTRUST Financial Advisors's PFE Position: Q2 2026 in Review

CAPTRUST Financial Advisors increased its Pfizer (PFE) stake by 4.1% in Q2 2026, buying an estimated $3.74M and bringing the position to 3,628,237 shares worth $87.4M. The position accounts for 0.13% of the portfolio, ranked #133.

CAPTRUST Financial Advisors first reported a position in PFE in Q2 2017 and has held it in 37 quarters since. The position peaked at $158M in Q1 2025. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • CAPTRUST Financial Advisors held 3,628,237 shares of Pfizer worth $87.4M as of Q2 2026.
  • CAPTRUST Financial Advisors bought 142,789 Pfizer shares in Q2 2026, an estimated $3.74M.
  • Pfizer made up 0.13% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #133 holding.
  • CAPTRUST Financial Advisors first reported a position in Pfizer in Q2 2017 and has held it in 37 quarters since.
  • CAPTRUST Financial Advisors's Pfizer position peaked at $158M in Q1 2025.
  • 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.